Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vitamin D3 improved hypoxia-induced lung injury by inhibiting the complement and coagulation cascade and autophagy pathway. | BMC Pulm Med | 2024 | 38166725 | PubTator, text mining | PubMed |
| Factor XI and coagulation. Factor XI inhibitors - antithrombotic perspectives. | Rom J Intern Med | 2024 | 38153875 | PubTator, text mining | PubMed |
| Elevated factor XI is associated with increased risk of recurrent cerebral venous sinus thrombosis: a cohort study. | J Thromb Thrombolysis | 2024 | 38145433 | PubTator, text mining | PubMed |
| Targeting factor XI and factor XIa to prevent thrombosis. | Blood | 2024 | 38142404 | PubTator, text mining | PubMed |
| Effect of Three-Day Atorvastatin Administration on Coagulation Factors in Patients With Prior Venous Thromboembolism and Healthy Subjects: A Preliminary Study. | J Cardiovasc Pharmacol | 2024 | 38117119 | PubTator, text mining | PubMed |
| A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment. | J Thromb Haemost | 2024 | 38103737 | PubTator, text mining | PubMed |
| Increased factor XI but not factor XII is associated with enhanced inflammation and impaired fibrin clot properties in patients with eosinophilic granulomatosis with polyangiitis. | Clin Exp Rheumatol | 2024 | 38079326 | PubTator, text mining | PubMed |
| Increased contact activated endogenous thrombin potential in pregnant women with preeclampsia. | Blood Coagul Fibrinolysis | 2024 | 38051647 | PubTator, text mining | PubMed |
| Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities. | J Thromb Haemost | 2024 | 38029854 | PubTator, text mining | PubMed |
| Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial. | Arterioscler Thromb Vasc Biol | 2024 | 37970718 | PubTator, text mining | PubMed |
| Design, expression and biological evaluation of DX-88mut as a novel selective factor XIa inhibitor for antithrombosis. | Bioorg Chem | 2024 | 37924755 | PubTator, text mining | PubMed |
| High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation. | J Thromb Haemost | 2024 | 37813198 | PubTator, text mining | PubMed |
| Effect of factor XI inhibition on tumor cell-induced coagulation activation. | J Thromb Haemost | 2024 | 37751848 | PubTator, text mining | PubMed |
| Factor XI as a therapeutic target in neuroinflammatory disease. | Curr Opin Hematol | 2024 | 37694771 | PubTator, text mining | PubMed |
| Plasma Kallikrein as a Forgotten Clotting Factor. | Semin Thromb Hemost | 2024 | 37072020 | PubTator, text mining | PubMed |
| Targeting the Contact Pathway of Coagulation for the Prevention and Management of Medical Device-Associated Thrombosis. | Semin Thromb Hemost | 2024 | 37044117 | PubTator, text mining | PubMed |
| Substrates, Cofactors, and Cellular Targets of Coagulation Factor XIa. | Semin Thromb Hemost | 2024 | 36940715 | PubTator, text mining | PubMed |
| [Prevention of hemorrhagic complications after operations performed on the background of anticoagulant therapy]. | Angiol Sosud Khir | 2023 | 41776884 | PubTator, text mining | PubMed |
| Liver cirrhosis and complications from the perspective of dysbiosis. | Front Med (Lausanne) | 2023 | 38293307 | PubTator, text mining | PubMed |
| Therapeutic potential of oncolytic viruses in the era of precision oncology. | Biomater Transl | 2023 | 38283919 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=14